SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Genetic association analysis of 77,539 genomes reveals rare disease etiologies.

Greene, D; Genomics England Research Consortium, ; Pirri, D; Frudd, K; Sackey, E; Al-Owain, M; Giese, APJ; Ramzan, K; Riaz, S; Yamanaka, I; et al. Greene, D; Genomics England Research Consortium; Pirri, D; Frudd, K; Sackey, E; Al-Owain, M; Giese, APJ; Ramzan, K; Riaz, S; Yamanaka, I; Boeckx, N; Thys, C; Gelb, BD; Brennan, P; Hartill, V; Harvengt, J; Kosho, T; Mansour, S; Masuno, M; Ohata, T; Stewart, H; Taibah, K; Turner, CLS; Imtiaz, F; Riazuddin, S; Morisaki, T; Ostergaard, P; Loeys, BL; Morisaki, H; Ahmed, ZM; Birdsey, GM; Freson, K; Mumford, A; Turro, E (2023) Genetic association analysis of 77,539 genomes reveals rare disease etiologies. Nat Med, 29 (3). pp. 679-688. ISSN 1546-170X https://doi.org/10.1038/s41591-023-02211-z
SGUL Authors: Ostergaard, Pia

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (6MB) | Preview
[img]
Preview
PDF Accepted Version
Available under License Creative Commons Attribution.

Download (2MB) | Preview

Abstract

The genetic etiologies of more than half of rare diseases remain unknown. Standardized genome sequencing and phenotyping of large patient cohorts provide an opportunity for discovering the unknown etiologies, but this depends on efficient and powerful analytical methods. We built a compact database, the 'Rareservoir', containing the rare variant genotypes and phenotypes of 77,539 participants sequenced by the 100,000 Genomes Project. We then used the Bayesian genetic association method BeviMed to infer associations between genes and each of 269 rare disease classes assigned by clinicians to the participants. We identified 241 known and 19 previously unidentified associations. We validated associations with ERG, PMEPA1 and GPR156 by searching for pedigrees in other cohorts and using bioinformatic and experimental approaches. We provide evidence that (1) loss-of-function variants in the Erythroblast Transformation Specific (ETS)-family transcription factor encoding gene ERG lead to primary lymphoedema, (2) truncating variants in the last exon of transforming growth factor-β regulator PMEPA1 result in Loeys-Dietz syndrome and (3) loss-of-function variants in GPR156 give rise to recessive congenital hearing impairment. The Rareservoir provides a lightweight, flexible and portable system for synthesizing the genetic and phenotypic data required to study rare disease cohorts with tens of thousands of participants.

Item Type: Article
Additional Information: Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. © The Author(s) 2023
Keywords: Humans, Rare Diseases, Bayes Theorem, Genotype, Genome-Wide Association Study, Phenotype, Membrane Proteins, 11 Medical and Health Sciences, Immunology
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: Nat Med
ISSN: 1546-170X
Language: eng
Dates:
DateEvent
16 March 2023Published
6 January 2023Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
UNSPECIFIEDNational Institute for Health Researchhttp://dx.doi.org/10.13039/501100000272
UNSPECIFIEDWellcome Trusthttp://dx.doi.org/10.13039/100004440
UNSPECIFIEDCancer Research UKhttp://dx.doi.org/10.13039/501100000289
UNSPECIFIEDMedical Research Councilhttp://dx.doi.org/10.13039/501100000265
RE/18/1/34212British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
219506/Z/19/ZWellcome Trusthttp://dx.doi.org/10.13039/100004440
MR/V037617/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
PG/17/33/32990British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
PG/20/16/35047British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
CRSII5_177191/1Swiss Federal National Fund for Scientific ResearchUNSPECIFIED
MR/P011543/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
RG/17/7/33217British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
C14/19/096KU Leuvenhttp://dx.doi.org/10.13039/501100004040
G072921NFonds Wetenschappelijk Onderzoekhttp://dx.doi.org/10.13039/501100003130
R01DC016295National Institute on Deafness and Other Communication Disordershttp://dx.doi.org/10.13039/100000055
85722King Salman Center for Disability Researchhttp://dx.doi.org/10.13039/501100019345
PubMed ID: 36928819
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/115131
Publisher's version: https://doi.org/10.1038/s41591-023-02211-z

Actions (login required)

Edit Item Edit Item